Neonatal diabetes mellitus around the world: Update 2024
Journal of Diabetes Investigation · 2024-12 · 15 (12) · 1711-1724
DOI: 10.1111/jdi.14312 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 30.09.2024. Verfasst von Fabrizio Barbetti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Monogenic Diabetes Clinic, Endocrinology and Diabetes Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KANKENHI, Italian Ministry of Health, Ministero della Salute.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Neonatal diabetes mellitus (NDM), defined as diabetes with an onset during the first 6 months of life, is a rare form of monogenic diabetes. The initial publications on this condition began appearing in the second half of the 1990s and quite surprisingly, the search for new NDM genes is still ongoing with great vigor. Between 2018 and early 2024, six brand new NDM‐genes have been discovered ( CNOT1 , FICD , ONECUT1 , PDIA6 , YIPF5 , ZNF808 ) and three genes known to cause different diseases were identified as NDM‐genes ( EIF2B1 , NARS2 , KCNMA1 ). In addition, NDM cases carrying mutations in three other genes known to give rise to diabetes during childhood have been also identified ( AGPAT2 , BSCL2 , PIK3R1 ). As a consequence, the list of NDM genes now exceeds 40. This genetic heterogeneity translates into many different mechanism(s) of disease that are being investigated with state‐of‐the‐art methodologies, such as induced pluripotent stem cells (iPSC) and human embryonic stem cells (hESC) manipulated with the CRISPR technique of genome editing. This diversity in genetic causes and the pathophysiology of diabetes dictate the need for a variety of therapeutic approaches. The aim of this paper is to provide an overview on recent achievements in all aspects of this area of research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Monogenic Diabetes Clinic, Endocrinology and Diabetes Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
- Pediatric Endocrine Division, Sheikh Shakhbout Medical City and College of Medicine and Health Science, Khalifa University, Abu Dhabi, UAE.
- Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
ORCID-Profile: Fabrizio Barbetti, Asma Deeb, Shigeru Suzuki
Förderung
- JSPS KANKENHI
- Italian Ministry of Health
- Ministero della Salute
Zitieren
APA
Barbetti, F., Deeb, A., & Suzuki, S. (2024). Neonatal diabetes mellitus around the world: Update 2024. Journal of Diabetes Investigation, 15(12), 1711-1724. https://doi.org/10.1111/jdi.14312
Vancouver
Barbetti F, Deeb A, Suzuki S. Neonatal diabetes mellitus around the world: Update 2024. Journal of Diabetes Investigation. 2024;15(12):1711-1724. doi:10.1111/jdi.14312
BibTeX
@article{Barbetti2024,
author = {Barbetti, Fabrizio and Deeb, Asma and Suzuki, Shigeru},
title = {Neonatal diabetes mellitus around the world: Update 2024},
journal = {Journal of Diabetes Investigation},
year = {2024},
volume = {15},
number = {12},
pages = {1711--1724},
doi = {10.1111/jdi.14312}
}
EUVIMED